Vivo Capital

Vivo Capital as of Sept. 30, 2017

Portfolio Holdings for Vivo Capital

Vivo Capital holds 29 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker)
Portfolio Weight
Valued At
Change in Shares
Share Count
Share Price
Biohaven Pharmaceutical Holding 14.9 $74M 2.0M 37.38
Aclaris Therapeutics (ACRS) 14.9 $74M 2.9M 25.81
Ascendis Pharma A S (ASND) 12.9 $64M 1.8M 36.25
Nabriva Therapeutics 6.7 $33M 4.1M 8.19
Kala Pharmaceuticals 5.3 $27M 1.2M 22.84
Verona Pharma Plc ads (VRNA) 4.6 $23M 1.5M 15.35
Strongbridge Bioph shs usd 4.1 $20M 3.0M 6.90
Selecta Biosciences 4.1 $20M 1.1M 18.25
Codexis (CDXS) 4.1 $20M 3.1M 6.65
Eiger Biopharmaceuticals 4.0 $20M 1.8M 11.00
Aimmune Therapeutics 3.9 $19M 777k 24.79
Advanced Accelerat spon ads each rep 2 ord 3.4 $17M 249k 67.62
Kadmon Hldgs 2.3 $11M 3.3M 3.35
Amyris 1.8 $9.0M 2.8M 3.20
Zai Lab (ZLAB) 1.8 $8.8M 325k 27.00
Aurinia Pharmaceuticals (AUPH) 1.5 $7.6M 1.2M 6.27
Soleno Therapeutics 1.5 $7.6M 15M 0.52
Agile Therapeutics 1.4 $6.8M 1.5M 4.46
Regenxbio Inc equity us cm (RGNX) 1.1 $5.4M 164k 32.95
Foamix Pharmaceuticals 1.0 $4.7M 855k 5.55
Trevena 0.9 $4.4M 1.7M 2.55
Biopharmx 0.8 $4.1M 14M 0.29
Sierra Oncology 0.8 $3.8M 2.4M 1.55
Crispr Therapeutics (CRSP) 0.5 $2.7M 149k 17.87
Revance Therapeutics (RVNC) 0.4 $2.1M 77k 27.55
Akari Therapeutics 0.4 $2.1M 346k 6.14
Kalvista Pharmaceuticals (KALV) 0.4 $2.0M 300k 6.73
Sunesis Pharmaceuticals Inc Ne 0.2 $970k 500k 1.94
Soleno Therapeutics Inc Wt S E w 0.0 $113k 944k 0.12